Increased Platelet Reactivity in HIV-1–Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy | Zendy

Claudette Satchell | Zendy; Jane A. O’Halloran | Zendy; Aoife G. Cotter | Zendy; Aaron Peace | Zendy; Eileen O’Connor | Zendy; Anthony Tedesco | Zendy; Eoin R. Feeney | Zendy; John S. Lambert | Zendy; Gerard Sheehan | Zendy; Dermot Kenny | Zendy; Patrick Mallon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased Platelet Reactivity in HIV-1–Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy

Author(s) -

Claudette Satchell,

Jane A. O’Halloran,

Aoife G. Cotter,

Aaron Peace,

Eileen O’Connor,

Anthony Tedesco,

Eoin R. Feeney,

John S. Lambert,

Gerard Sheehan,

Dermot Kenny,

Patrick Mallon

Publication year - 2011

Publication title -

the journal of infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jir509

Subject(s) - abacavir , platelet , medicine , epinephrine , p2y12 , pharmacology , immunology , endocrinology , human immunodeficiency virus (hiv) , viral load , platelet aggregation , antiretroviral therapy

Current or recent use of abacavir for treating human immunodeficiency virus type 1 (HIV-1) infection has been associated with increased rates of myocardial infarction (MI). Given the role of platelet aggregation in thrombus formation in MI and the reversible nature of the abacavir association, we hypothesized that patients treated with abacavir would have increased platelet reactivity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research